1. Home
  2. BDC vs LGND Comparison

BDC vs LGND Comparison

Compare BDC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$114.50

Market Cap

4.5B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$317.20

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
LGND
Founded
1902
1987
Country
United States
United States
Employees
N/A
68
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
BDC
LGND
Price
$114.50
$317.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$162.50
$256.29
AVG Volume (30 Days)
557.1K
478.4K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.16%
N/A
EPS Growth
23.13
N/A
EPS
1.30
N/A
Revenue
$2,715,194,000.00
N/A
Revenue This Year
$8.91
$1.25
Revenue Next Year
$4.70
$19.41
P/E Ratio
$88.78
$76.27
Revenue Growth
10.33
N/A
52 Week Low
$101.00
$114.00
52 Week High
$159.99
$320.99

Technical Indicators

Market Signals
Indicator
BDC
LGND
Relative Strength Index (RSI) 49.57 80.49
Support Level $112.81 $178.68
Resistance Level $122.61 N/A
Average True Range (ATR) 4.81 13.43
MACD -0.06 4.72
Stochastic Oscillator 20.70 98.11

Price Performance

Historical Comparison
BDC
LGND

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: